| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Thursday’s Close |
|---|---|---|---|---|---|
| NVS | Novartis AG | $85.13 | $197.65B | N/A |
Is a Beat in Store for Glaxo (GSK) This Earnings Season?
http://www.zacks.com/stock/news/887540/is-a-beat-in-store-for-glaxo-gsk-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-887540
Apr 24, 2020 - Glaxo's (GSK) Vaccines and Respiratory segments are likely to have driven sales in the first quarter. Results will provide clarity on the impact of coronavirus on the company's business.
0
Big Drug Stock Q1 Earnings Due on Apr 28: MRK, PFE and NVS
http://www.zacks.com/stock/news/891794/big-drug-stock-q1-earnings-due-on-apr-28-mrk-pfe-and-nvs?cid=CS-ZC-FT-analyst_blog:_earnings_preview_-_esp|earnings_preview_-_esp-891794
Apr 27, 2020 - Let us take a look at three big drug companies due to release their first-quarter financial results on Apr 28.
0
Top Research Reports for Intel, Novartis & Toyota
http://www.zacks.com/research-daily/891971/top-research-reports-for-intel-novartis-toyota?cid=CS-ZC-FT-research_daily-891971
Apr 27, 2020 - Top Research Reports for Intel, Novartis & Toyota
0
Novartis (NVS) Releases Positive Data on Enerzair Breezhaler
http://www.zacks.com/stock/news/1055165/novartis-nvs-releases-positive-data-on-enerzair-breezhaler?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1055165
Sep 08, 2020 - Novartis (NVS) posts favorable data on asthma treatment Enerzair Breezhaler at the ERS International Congress 2020.
0
Novartis Reports Positive Data on Beovu for DME Indication
http://www.zacks.com/stock/news/1058103/novartis-reports-positive-data-on-beovu-for-dme-indication?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1058103
Sep 14, 2020 - Novartis (NVS) announces positive data on Beovu from an ongoing late-stage study for the DME indication.
0
Novartis' Eye Drug's Safety Label Update Approved by EMA
http://www.zacks.com/stock/news/1058570/novartis-eye-drugs-safety-label-update-approved-by-ema?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1058570
Sep 15, 2020 - Novartis' (NVS) eye drug Beovu's safety label update receives approval from the Committee for Medicinal Products for Human Use.
0
Are Investors Undervaluing Ahold NV (ADRNY) Right Now?
http://www.zacks.com/stock/news/1060408/are-investors-undervaluing-ahold-nv-adrny-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-1060408
Sep 18, 2020 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
AbbVie Elezanumab Gets FDA's Fast Track and Orphan Drug Tags
http://www.zacks.com/stock/news/1068692/abbvie-elezanumab-gets-fdas-fast-track-and-orphan-drug-tags?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1068692
Sep 29, 2020 - AbbVie's (ABBV) elezanumab is presently being evaluated in a phase II study for spinal cord injury.
0